Cryptogenic ischemic stroke, stroke with no clear definable cause even after extensive workup, does not have fixed diagnostic criteria. Proportion of this type of stroke among overall ischemic stroke varies much, ranging from 16% to 39%. Majority of cryptogenic ischemic stroke is considered as embolism, and the concept of embolic stroke of undetermined source has been recently proposed. In particular, covert atrial fibrillation is drawing attention, and it was identified in 30% of patients in long-term observation using an insertable cardiac monitor. A next-generation insertable cardiac monitor is small and has the capability of remote monitoring. Thus, it has been in clinical use to detect atrial fibrillation in patients with cryptogenic ischemic stroke in the United States, Europe, and Australia. If atrial fibrillation would be identified, anticoagulants can be legally used for prevention of stroke recurrence, and could reduce its recurrence in patients with cryptogenic ischemic stroke. A request has been submitted by the Japan Stroke Society to the Ministry of Health, Labor and Welfare, Japan, indicating the high medical needs of the next-generation insertable cardiac monitor to detect covert atrial fibrillation after cryptogenic ischemic stroke. If the use of the device is approved, patients appropriate for the use should be selected based on detailed examination including head MRI in accordance with the current situation of medical practice in Japan.
View full abstract